Dallas, Texas 04/04/2014 (FINANCIALSTRENDS) – 3D Systems Corporation (NYSE:DDD) has gained Medical Modeling Inc, a heading organization in the field of customized surgical medicines and patient particular medicinal gadgets. The securing might help 3D Systems Corporation (NYSE:DDD) in its exertion to turn into the greatest player in customized 3d printed therapeutic gadgets.
3D Systems to coordinate its medicinal services exercises
3D Systems Corporation (NYSE:DDD) CEO and President Avi Reichental, said that the organization’s developing health awareness business joined with the dexterity of the Medical Modeling will help to make “biggest 3d printing based customized surgery and patient particular therapeutic gadget administration capacities accessible today. Alongside the securing, 3D Systems Corporation (NYSE:DDD) additionally expressed that it will streamline all its health awareness exercises into a solitary unit headed by Medical Modeling President Andy Christensen, who is presently being named as Vice President of3D Systems Corporation (NYSE:DDD), Personalized Surgery and Medical Devices.
3D Systems Corporation (NYSE:DDD) has made many various acquisitions over the past few years with the most recent one being Digital Play space, which might empower the organization to transform 3d printed toys. It is likewise making its vicinity felt in the 3d printed nourishment market with its Chefjet Food 3d printer, and a union with Hershey.
Words of Andy Christensen on Deal
On the arrangement, Medical Modeling President, Andy Christensen said, “We as of recently utilize the vast majority of 3ds’ heading proficient configuration to-assembling devices, including its Geomagic Freeform demonstrating programming and haptic apparatuses and propelled assembling Stereo lithography and Color jet Printing proficient evaluation 3D printers.” The official included that the organization is working in close coordinated effort with surgeons all around the globe on an assortment of patient cases. The arrangement with 3D Systems Corporation (NYSE:DDD) might help the organization in getting notable stage and assets that could improve general patient conclusions.